Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Pharmaceutical Industry Needs to Jump the Curve to Nanotech

Abstract:
In 2003, I wrote the book, "The Next Big Thing is Really Small: How Nanotechnology Will Change the Future of Your Business." In it, I outlined the many ways in which nanotechnology will impact the pharmaceutical industry in the near future. Recently, researchers at Children's Hospital in Boston have uncovered a method of reviving a once-promising cancer drug, TNP-470—which was cancelled in the mid-1990's due to concerns over toxicity.

Pharmaceutical Industry Needs to Jump the Curve to Nanotech

Minneapolis, MN | Posted on July 11th, 2008

The problem of toxicity is not a new one to the pharmaceutical industry. In fact, it is a big reason why so many early stage drugs fail to make it to market.

This vexing problem may soon be partially alleviated due to advances in nanotechnology. One advantage of reformulating drugs at the nanoscale is that they are water soluble and, as such, don't require the solvents which so often cause nasty side-effects in patients.

Another application being employed from the nanotechnology bag of tricks is to use nanoscale platforms such as micelles and dendrimers to prevent drugs from crossing the blood-brain barrier. In this fashion, older drugs may be reformulated so as to prevent certain drugs from wreaking havoc on the human brain. (This was one of the problems with TNP-470).

The pharmaceutical industry has invested billions of dollars developing promising drugs. Unfortunately, most developmental drugs end being shelved when it is found they cause some unintended consequence. Nanotechnology holds the promise that a handful of older drugs may now be revisited. Some may even find their way to the commercial marketplace.

With a single drug's ability to add billions of dollars to a pharmaceutical company's bottom-line, it is time many of them begin turning their attention to nanotechnology. It's a small technology, but it could pay big dividends.

####

About Jack Uldrich
Jack Uldrich is a renowned global futurist, independent scholar, sought-after business speaker, and best-selling author. His books include the best-selling, The Next Big Thing is Really Small: How Nanotechnology Will Change the Future of Your Business, and the award-winning, Into the Unknown: Leadership Lessons from Lewis & Clark’s Daring Westward Expedition. His latest book is Jump the Curve: 50 Essential Strategies to Help Your Company Stay Ahead of Emerging Technologies.

For more information, please click here

Contacts:
Jack Uldrich
612-267-1212

Copyright © Jack Uldrich

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Flexible electronics integrated with paper-thin structure for use in space January 17th, 2025

‘Brand new physics’ for next generation spintronics: Physicists discover a unique quantum behavior that offers a new way to manipulate electron-spin and magnetization to push forward cutting-edge spintronic technologies, like computing that mimics the human brain January 17th, 2025

Quantum engineers ‘squeeze’ laser frequency combs to make more sensitive gas sensors January 17th, 2025

How a milk component could eliminate one of the biggest challenges in treating cancer and other disease, including rare diseases: Nebraska startup to use nanoparticles found in milk to target therapeutics to specific cells January 17th, 2025

Blog sites

First measurement of electron energy distributions, could enable sustainable energy technologies June 5th, 2020

Novel Electrode Structure Provides New Promise for Lithium-Sulfur Batteries December 3rd, 2016

Peter Diamandis Thinks Nanotech Will Interface With Human Minds September 1st, 2016

Graphene-Enabled Paper Makes for Flexible Display August 1st, 2016

Nanomedicine

How a milk component could eliminate one of the biggest challenges in treating cancer and other disease, including rare diseases: Nebraska startup to use nanoparticles found in milk to target therapeutics to specific cells January 17th, 2025

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project